[Chronic hepatitis and liver cirrhosis]

Area of Science:

• Hepatology
• Virology
• Pathology

Background:

• Chronic hepatitis B virus infection is a significant risk factor for liver cirrhosis.
• Early identification of patients at high risk for cirrhosis progression is crucial for timely intervention.
• Hepatitis B surface antigen (HBsAg) and hepatitis B core antigen (HBcAg) are key viral markers in Hepatitis B Virus (HBV) infection.

Purpose of the Study:

• To evaluate the diagnostic utility of HBsAg and HBcAg in predicting cirrhosis development.
• To correlate the presence of these viral markers with established risk groups for cirrhosis.
• To investigate the association between HBsAg/HBcAg and the potential causes of cirrhosis in a cohort of liver biopsy patients.

Main Methods:

• Analysis of 349 liver biopsies, with 32 cases diagnosed with cirrhosis.
• Immunohistochemical detection of HBsAg and HBcAg in liver tissue.
• Comparison of marker prevalence across different patient risk groups and etiological categories of cirrhosis.

Main Results:

• The study identified a significant correlation between the presence of HBsAg and/or HBcAg and the development of cirrhosis.
• Specific patterns of HBsAg and HBcAg expression were associated with higher risk groups for cirrhosis.
• These viral markers aid in understanding the etiological contribution of HBV to liver cirrhosis.

Conclusions:

• HBsAg and HBcAg are valuable biomarkers for assessing cirrhosis risk in patients with chronic hepatitis.
• Integrating viral marker analysis with clinical risk assessment can improve patient stratification.
• These findings support the role of HBV in driving liver fibrosis and cirrhosis progression.